The global artificial intelligence in drug repurposing market stood at USD 1.3 billion in 2025 and is forecast to climb to USD 7.7 billion by 2033, growing at a CAGR of 24.5% between 2026 and 2033. North America leads with 52.9% share, oncology is the top application at 36.7%, and software & platform tools account for 66.6% of spend. Baricitinib was designed as a rheumatoid...

Drug Repurposing Market Analysis: Key Drivers and Insights The Drug Repurposing Market analysis highlights a rapidly evolving landscape where pharmaceutical companies are leveraging existing drugs to target new indications. MRFR reports that rising R&D costs and increasing regulatory pressures are pushing organizations toward repurposing strategies as a cost-effective alternative....

Drug Repurposing Market Technology and Innovation Outlook Technological innovation is transforming the Drug Repurposing Market Technology landscape, enabling faster identification of potential new uses for existing drugs. MRFR analysis highlights the adoption of artificial intelligence, machine learning, and bioinformatics as critical enablers in predicting drug-target interactions. These tools...

Healthcare and research organizations across North America are increasingly utilizing clinical databases, genomic information, and computational platforms for repurposing research. Data-driven approaches can improve the identification of promising drug candidates. Continued digital transformation is supporting the growth of technology-enabled repurposing programs. The Drug Repurposing Market...